Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


AgBiTech opens US biopesticide laboratory

The Australian biopesticide company, AgBiTech (Toowoomba, Queensland), has opened a US research laboratory at the University of Missouri Life Science Business Incubator in Columbia, Missouri. The establishment of a US laboratory will allow the company to develop products relevant to international markets and not just Australia.  "Investing in a dedicated research facility in North America gives AgBiTech greater flexibility to respond to farmers' needs worldwide," says chief executive officer Anthony Hawes. The company's five-year goal is to release several new products targeting significant agricultural pests. Its Helicoverpa zea nucleopolyhedrovirus bioinsecticide was introduced in Brazil this year as HzNPV CCAB (Agrow No 670, p 25). The company is also targeting the US and Europe (Agrow No 671, p 3). The first product to emerge from the US laboratory will be for use against fall armyworms (Spodoptera frugiperda ). AgBiTech is funding a co-operative research and development project with the USDA and plans to start the registration process in early 2014.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts